Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OSR Holdings, Inc. (OSRH : NSDQ)
 
 • Company Description   
Bellevue Life Sciences Acquisition Corp. is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Bellevue Life Sciences Acquisition Corp. is based in Bellevue, Washington.

Number of Employees: 4

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.50 Daily Weekly Monthly
20 Day Moving Average: 18,007,868 shares
Shares Outstanding: 35.10 (millions)
Market Capitalization: $17.62 (millions)
Beta: 0.86
52 Week High: $1.79
52 Week Low: $0.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.66% -19.78%
12 Week 19.52% 10.49%
Year To Date -11.01% -16.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10900 NE 4TH STREET SUITE 2300
-
BELLEVUE,WA 98004
USA		 ph: 425-635-7700
fax: -		 ir@osr-holdings.com http://www.osr-holdings.com
 
 • General Corporate Information   
Officers
Kuk Hyoun Hwang - Chief Executive Officer and Director
Gihyoun Bang - Chief Financial Officer
Seng Chin Mah - Director
Hyuk Joo Jee - Director
Hyuk Joo Jee - Director

Peer Information
OSR Holdings, Inc. (CHCR)
OSR Holdings, Inc. (ESRX)
OSR Holdings, Inc. (MYDP)
OSR Holdings, Inc. (COR)
OSR Holdings, Inc. (GBCS)
OSR Holdings, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 68840D102
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/13/26
Share - Related Items
Shares Outstanding: 35.10
Most Recent Split Date: (:1)
Beta: 0.86
Market Capitalization: $17.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.14
Price/Cash Flow: -
Price / Sales: 6.70
EPS Growth
vs. Year Ago Period: 91.35%
vs. Previous Quarter: 43.75%
Sales Growth
vs. Year Ago Period: -36.40%
vs. Previous Quarter: 27.03%
ROE
03/31/26 - -7.24
12/31/25 - -13.53
09/30/25 - -10.59
ROA
03/31/26 - -5.41
12/31/25 - -10.17
09/30/25 - -8.16
Current Ratio
03/31/26 - 0.16
12/31/25 - 0.16
09/30/25 - 0.21
Quick Ratio
03/31/26 - 0.14
12/31/25 - 0.15
09/30/25 - 0.20
Operating Margin
03/31/26 - -363.26
12/31/25 - -619.82
09/30/25 - -422.36
Net Margin
03/31/26 - -363.26
12/31/25 - -619.82
09/30/25 - -422.36
Pre-Tax Margin
03/31/26 - -814.53
12/31/25 - -994.08
09/30/25 - -665.67
Book Value
03/31/26 - 3.63
12/31/25 - 4.95
09/30/25 - 6.22
Inventory Turnover
03/31/26 - 7.84
12/31/25 - 7.02
09/30/25 - 5.52
Debt-to-Equity
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 0.21
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©